Results

Total Results: 1,887 records

Showing results for "testing".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
    January 01, 2011 - What are the adverse effects or harms associated with testing using newer and/or older markers of iron … Studies did not attribute these deaths to either testing or treatment. … What are the adverse effects or harms associated with testing using newer and/or older markers of … Studies did not attribute these deaths to either testing or any treatment. … A randomized trial of iron deficiency testing strategies in hemodialysis patients.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
    December 31, 2022 - What are the unintended consequences of antibody testing after SARS-CoV-2 infection? … Currently, the most salient use of antibody testing is as a correlate of protection against infection … This review does not address all potential uses of antibody testing in clinical practice. … Most notably, this review does not address the use of antibody testing for the diagnosis of SARS-CoV … Current Testing Strategies for SARS-CoV-2 in the United States.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-infection-prevention-mdro-protocol.pdf
    July 01, 2023 - environments, including those centering around the patient microbiome (including MDRO surveillance testing … Safer II (2013) chapter 7 included barrier isolation precautions while adding routine surveillance testing … hospital populations (such as all intensive care unit [ICU] patients) regardless of surveillance testing … Population Adult patients (18+ years) Pediatric patients (under 18 years) Intervention • Surveillance testing … or alternative transmission-based precautions N/A Outcome • Clinical outcomes o Surveillance testing
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
    November 01, 2019 - O= Order, C= Consider, D= Diagnosis, M= Monitor, L= Laboratory Testing, R= Recommendation Task 2. … In the software development lifecycle, this stage of testing is often referred to as “black box” testing … The CDS Connect Authoring Tool provides support for unit testing (testing of combinations of patient … We recommend that AHRQ consider developing an EHR testing environment to facilitate testing and quality … Extent of Adherence to Trustworthy Standards (NEATS) InstrumentDeveloping and Testing NEATS.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-machine-learning-screening.pdf
    November 01, 2019 - Screening Exercise for the User Experiences Testing Appendix B. … Key differences between the tools played an important role in the user experience testing by exposing … We received ethical approval to complete the user experience testing from the University of Alberta … Before beginning the user experience testing, the screening exercise and survey were pilot tested by … Screening Exercise for the User Experiences Testing Screening Exercise Instructions for Each Tool
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
    January 08, 2013 - CER #50: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children Original release date: March, 2012 Surveillance Report: March, 2013 Key Findings: - All conclusions from the original CER are up to date. Summary Decisio…
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
    March 01, 2012 - 1 Comparative Effectiveness Review Number 50 Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children Executive Summary Background Musculoskeletal (MSK) pain is common in children and adolescents, with an estimated prevalence rangin…
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guide-editorial_methods.pdf
    July 01, 2012 - compared to a reference standard, in this case, invasive angiography) and the downstream result of testing
  9. effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
    December 01, 2013 - Overall High Impact Potential: Xpert MTB/RIF test for detection and drug sensitivity testing of M. … Susceptibility to other agents would still have to be guided by traditional testing methods. … , which could lead to decentralization of testing, some experts thought. … Molecular-based diagnostic testing for clostridium difficile. … Targeted testing and the diagnosis of latent tuberculosis infection and tuberculosis disease.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_disposition-comments.pdf
    January 27, 2016 - The sentences about POC testing are impossible to understand. Please revise. … Edited sentences about POC testing to improve clarity. 74. … CRP testing is referred to several times throughout the CER. … You write S. pneumococcal Point-of-care testing (Rapid Strep Test). … The classification of 'rapid strep" testing as testing for Streptococcus pneumoniae is incorrect.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-mobile-apps-disposition-of-comments.pdf
    May 20, 2022 - Pilot testing with 10 apps is inadequate (possible bias in app selection); more detail is needed on … The section on pilot testing has been revised based on results from further rounds of testing. … The final report describes the pre-pilot test of 10 apps and six rounds of dual-review pilot testing … We have reported the interrater reliability for the additional rounds of pilot testing, which is … However, during the pilot testing phase, we were unable to test the framework on apps that could
  12. effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
    January 01, 2012 - Overall High Impact Potential: Xpert MTB/RIF test for detection and drug sensitivity testing of M. … Susceptibility to other agents would still have to be guided by traditional testing methods. … Susceptibility to other agents would still have to be guided by traditional testing methods. … , which could lead to decentralization of testing, some experts thought. … Targeted testing and the diagnosis of latent tuberculosis infection and tuberculosis disease.
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-abnormalities-tests-update_research-protocol.pdf
    July 01, 2010 - Positive predictive value: the probability of a woman actually having breast cancer after testing positive … Negative predictive value: the probability of a woman actually not having breast cancer after testing
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-informed-care-executive-summary.pdf
    January 01, 2025 - Another consideration when testing a full system of TIC is the availability of a sufficient number of … understanding of how singular intervention components interact to influence key outcomes prior to efficacy testing
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-disposition-comments.pdf
    May 14, 2025 - May 14, 2025 7 Commentator and Affiliation Section Comment Response about harms of additional testing … demonstrated to yield a favorable positive predictive value in the 43-44% range (also a product of testing … Rationale: The inherent value of MCED testing is in its ability to detect a broad range of cancers. … Exact Sciences’ Response: When considering harms associated with MCSTs or additional testing following … Rationale: Potential harms of MCED testing are primarily related to the risk of false- positive results
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_research-protocol.pdf
    December 23, 2014 - The testing strategies used in hospitals are rapidly evolving. … However, given the rapid evolution of testing strategies, studies of diagnostic test performance often … Since there has been some growth in the diagnostic testing literature, and diagnostic testing continues … Does testing strategy impact patient health or health system outcomes? … Framework for diagnostic testing and treatment Source: www.effectivehealthcare.ahrq.gov
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
    March 01, 2017 - This threshold also may be defined based upon formal cognitive testing scores below norms for younger … These theories support prevention trials testing cognitive training, physical exercise, cardiovascular … functional abnormalities earlier or with greater sensitivity than is possible with behavior-based testing … In other cases, theories of brain function (e.g., neuroplasticity) justify the development and testing … The substantial work on modifiable risk factors would be better informed by testing interventions that
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
    March 01, 2017 - This threshold also may be defined based upon formal cognitive testing scores below norms for younger … These theories support prevention trials testing cognitive training, physical exercise, cardiovascular … functional abnormalities earlier or with greater sensitivity than is possible with behavior-based testing … In other cases, theories of brain function (e.g., neuroplasticity) justify the development and testing … The substantial work on modifiable risk factors would be better informed by testing interventions that
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-health-care-practice-delivery.pdf
    November 01, 2022 - , treatments for depression, management of opioid overdose) ◆ Diagnostic tests (e.g., noninvasive testing
  20. effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
    September 21, 2012 - If we make a Bonferroni correction for multiple testing in order to maintain the correct Type-I error … biological and epidemiological evidence; detailed description of a statistical analysis plan for how testing … achieve Possible Difficult to characterize sampling properties (e.g., confidence intervals) Power of testing … To do this, chance findings should be evaluated by testing for interaction; biases should be avoided … - Describe methods to adjust for multiple testing, if applicable. o Describe how confounding

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: